US equities |
MU $1,097.39 ▲+3.03% NVDA $230.86 ▲+1.09% SNDK $1,787.69 ▲+2.75% INTC $120.00 ▼-0.19% AAPL $330.32 ▼-0.81% GOOGL $338.24 ▼-1.70% TSLA $354.11 ▼-0.20% AMD $615.73 ▲+0.65%
FinancialContent

Bone Biologics Corp - Common Stock (NQ:BBLG)

0.4750 -0.0213 (-4.29%)
Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,504
Open 0.4700
Bid (Size) 0.4700 (600)
Ask (Size) 0.4963 (2,200)
Prev. Close 0.4963
Today's Range 0.4663 - 0.4812
52wk Range 0.4280 - 2.890
Shares Outstanding 1,795,260
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Bone Biologics Expands Trial Sites
Addition of three sites strengthens expectation to complete enrollment by year-end 2026 
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire

Performance

YTD
-69.2%
-69.2%
1 Month
-15.7%
-15.7%
3 Month
-66.5%
-66.5%
6 Month
-61.7%
-61.7%
1 Year
-83.0%
-83.0%

More News

Read More
News headline image
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
Topics Stocks
News headline image
Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
Discover the most active stocks in Thursday's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Top stock movements in today's session. ↗
Via Chartmill
News headline image
Which stocks are gapping on Thursday? ↗
Via Chartmill
News headline image
Top movers in Thursday's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook
From Bone Biologics Corporation
Via Business Wire
News headline image
Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference
From Bone Biologics Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Bone Biologics Announces Closing of $5.0 Million Public Offering
From Bone Biologics Corporation
Via Business Wire
News headline image
Why Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga

Frequently Asked Questions

Is Bone Biologics Corp - Common Stock publicly traded?
Yes, Bone Biologics Corp - Common Stock is publicly traded.
What exchange does Bone Biologics Corp - Common Stock trade on?
Bone Biologics Corp - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bone Biologics Corp - Common Stock?
The ticker symbol for Bone Biologics Corp - Common Stock is BBLG on the Nasdaq Stock Market
What is the current price of Bone Biologics Corp - Common Stock?
The current price of Bone Biologics Corp - Common Stock is 0.4750
When was Bone Biologics Corp - Common Stock last traded?
The last trade of Bone Biologics Corp - Common Stock was at 10/01/26 04:00 PM ET
What is the market capitalization of Bone Biologics Corp - Common Stock?
The market capitalization of Bone Biologics Corp - Common Stock is 852.75K
How many shares of Bone Biologics Corp - Common Stock are outstanding?
Bone Biologics Corp - Common Stock has 853K shares outstanding.